RSI indicator

UnitedHealth raises 2026 earnings guidance above $18.25 per share after Q1 beat. Stock rises 3.2% despite overbought signals and Medicare drug coverage challenges.

UnitedHealth surged 8% to $303.98 on favorable Medicare Advantage reimbursement decision, testing key resistance level ahead of earnings.

Nine US stocks down 25-43% YTD show oversold technicals and significant valuation discounts amid market volatility, presenting potential value opportunities.

Amazon stock fell 12% in 2024 amid valuation concerns and heavy AI infrastructure spending, though analysts suggest potential undervaluation and maintain constructive long-term outlooks.